220 related articles for article (PubMed ID: 34378080)
1. Rescued from desperation: adult-onset Still's disease with life-threatening interstitial lung disease and macrophage activation : Successful treatment by Tocilizumab.
Zhang G; Liu W; Zhang X; Liu L
Z Rheumatol; 2022 May; 81(4):335-338. PubMed ID: 34378080
[TBL] [Abstract][Full Text] [Related]
2. Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide.
Ohmura SI; Uehara K; Yamabe T; Tamechika S; Maeda S; Naniwa T
Mod Rheumatol Case Rep; 2020 Jul; 4(2):202-207. PubMed ID: 33086994
[TBL] [Abstract][Full Text] [Related]
3. Macrophage Activation Syndrome Associated With Adult Onset Still's Disease.
Gulzar M; Sabir A; Hamdani MA; Saadia A
J Ayub Med Coll Abbottabad; 2018; 30(2):289-292. PubMed ID: 29938438
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
Yamabe T; Ohmura SI; Uehara K; Naniwa T
Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
[TBL] [Abstract][Full Text] [Related]
5. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.
Kobayashi M; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Mod Rheumatol; 2011 Feb; 21(1):92-6. PubMed ID: 20737186
[TBL] [Abstract][Full Text] [Related]
6. Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab.
Savage E; Wazir T; Drake M; Cuthbert R; Wright G
Rheumatology (Oxford); 2014 Jul; 53(7):1352-3. PubMed ID: 24609056
[No Abstract] [Full Text] [Related]
7. Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease.
Banse C; Vittecoq O; Benhamou Y; Gauthier-Prieur M; Lequerré T; Lévesque H
Joint Bone Spine; 2013 Dec; 80(6):653-5. PubMed ID: 23751410
[TBL] [Abstract][Full Text] [Related]
8. A Recurrent Case of Adult-onset Still's Disease with Concurrent Acalculous Cholecystitis and Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis Successfully Treated with Combination Immunosuppressive Therapy.
Arai Y; Ishikawa Y; Abe K; Kato Y; Abe D; Fujiwara M; Kita Y
Intern Med; 2021 Jun; 60(12):1955-1961. PubMed ID: 33518559
[TBL] [Abstract][Full Text] [Related]
9. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
11. Possible macrophage activation syndrome following initiation of adalimumab in a patient with adult-onset Still's disease.
Souabni L; Dridi L; Ben Abdelghani K; Kassab S; Chekili S; Laater A; Zakraoui L
Pan Afr Med J; 2014; 17():94. PubMed ID: 25018831
[TBL] [Abstract][Full Text] [Related]
12. Reintroduction of tocilizumab elicited macrophage activation syndrome in a patient with adult-onset Still's disease with a previous successful tocilizumab treatment.
Naniwa T; Uehara K; Yamabe T; Ohmura SI
Mod Rheumatol Case Rep; 2021 Jul; 5(2):360-364. PubMed ID: 32883165
[TBL] [Abstract][Full Text] [Related]
13. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.
Bindoli S; Galozzi P; Doria A; Sfriso P
Joint Bone Spine; 2023 Mar; 90(2):105524. PubMed ID: 36623798
[TBL] [Abstract][Full Text] [Related]
14. Ruxolitinib rescued the macrophage activation syndrome in adult-onset Still's disease with delayed hypersensitivity reaction to tocilizumab.
Fu Y; Li J; Xu A; Chen J; Wang X; Ye S
Rheumatology (Oxford); 2023 Jul; 62(7):e223-e225. PubMed ID: 36519834
[No Abstract] [Full Text] [Related]
15. Recent advances and evolving concepts in Still's disease.
Ruscitti P; Cantarini L; Nigrovic PA; McGonagle D; Giacomelli R
Nat Rev Rheumatol; 2024 Feb; 20(2):116-132. PubMed ID: 38212542
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Plate A; Vallelian F; Herfs G
Praxis (Bern 1994); 2016; 105(25):1503-1506. PubMed ID: 27976958
[No Abstract] [Full Text] [Related]
17. Comparison of MS score and HScore for the diagnosis of adult-onset Still's disease-associated macrophage activation syndrome.
Zhang L; Yang X; Li TF; Liu X; Liu S
Ann Rheum Dis; 2022 Jun; 81(6):e99. PubMed ID: 32611598
[No Abstract] [Full Text] [Related]
18. [Adult onset Still's disease with small vessel vasculitis].
Hoff P; Hoyer BF; Schneider U; Kneitz C; Burmester GR; Buttgereit F
Z Rheumatol; 2015 Aug; 74(6):540-2. PubMed ID: 26231832
[TBL] [Abstract][Full Text] [Related]
19. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
20. Adult-onset Still's disease with disseminated intravascular coagulation and hemophagocytic syndrome: a case report.
Mimura T; Shimodaira M; Kibata M; Tsukadaira A; Shirahata K
BMC Res Notes; 2014 Dec; 7():940. PubMed ID: 25532568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]